TRUMF - Inari Medical Seeks Commercialization Capital In U.S. IPO
Quick Take
Inari Medical (NARI) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.
The firm develops and markets medical devices to treat patients with venous conditions.
NARI is growing rapidly and nearing breakeven. I’ll provide an update when we learn more about pricing and valuation from management.
Company & Technology
Irvine, California-based Inari was founded to develop two catheter-based thrombectomy FDA-approved devices to treat patients with deep vein thrombosis and pulmonary embolism.
Management is headed by President and CEO William Hoffman,